Monash study maps how ageing changes cancer-fighting T cells
Researchers at Monash University found distinct chromatin changes in CD8 T cells from ageing mice, including reduced access to genes linked to regenerative capacity and increased activity of genes associated with inhibition. The study, published in Science Immunology, also identified a regulatory-like T-cell population among aged mice; the findings are preclinical, not evidence of a treatment for people.
Bottom line — The mouse findings point to several routes of immune decline, but human relevance remains to be established.
Go deeper 6
-
LifeScience.net’s summary says the researchers traced dysfunction to changes in three regulatory layers: stemness, restraint and terminal inhibition.
-
The study found reduced accessibility of genes associated with T-cell stemness, suggesting lower regenerative potential.
-
Exhausted memory T cells showed reduced accessibility of genes that normally restrain differentiation after activation.
-
Both senescent virtual-memory cells and exhausted memory cells showed greater accessibility of terminal-inhibitory genes.
-
LifeScience.net reports that Fcgr2b, which encodes the inhibitory receptor FcγRIIb, was elevated in a subset of aged virtual-memory cells with regulatory characteristics.
-
The Monash team’s findings concern mouse models; the articles do not establish that the same mechanisms can be targeted in people.